Your browser doesn't support javascript.
loading
A randomized multicenter study evaluating Xolair persistence of response after long-term therapy.
Ledford, Dennis; Busse, William; Trzaskoma, Benjamin; Omachi, Theodore A; Rosén, Karin; Chipps, Bradley E; Luskin, Allan T; Solari, Paul G.
Afiliação
  • Ledford D; Morsani College of Medicine and James A. Haley VA Hospital, University of South Florida, Tampa, Fla. Electronic address: dledford@health.usf.edu.
  • Busse W; University of Wisconsin, Madison, Wis.
  • Trzaskoma B; Genentech, Inc, South San Francisco, Calif.
  • Omachi TA; Genentech, Inc, South San Francisco, Calif.
  • Rosén K; Genentech, Inc, South San Francisco, Calif.
  • Chipps BE; Capital Allergy & Respiratory Disease Center, Sacramento, Calif.
  • Luskin AT; Dean Clinic, Madison, Wis.
  • Solari PG; Genentech, Inc, South San Francisco, Calif.
J Allergy Clin Immunol ; 140(1): 162-169.e2, 2017 Jul.
Article em En | MEDLINE | ID: mdl-27826098

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos / Omalizumab Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos / Omalizumab Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2017 Tipo de documento: Article